Novogen is a biotechnology company based in Australia and the US. It was formed in 1992 with private investor backing to commercialise the isoflavonoid drug technology platform that forms the basis of the current Novogen R&D program.
| Registrars: |
| Address: | |
| Phone: | |
| Fax: | |
| Website: | |
| Email: |
| ISIN: | AU000000KZA9 |